Crystal structure of a heterodimer of editosome interaction proteins in complex with two copies of a cross-reacting nanobody by Park, Young-Jun et al.
Crystal structure of a heterodimer of editosome
interaction proteins in complex with two copies
of a cross-reacting nanobody
Young-Jun Park
1, Els Pardon
2,3, Meiting Wu
1, Jan Steyaert
2,3 and Wim G. J. Hol
1,*
1Department of Biochemistry, Biomolecular Structure Center, School of Medicine, University of Washington,
PO Box 357742, Seattle WA 98195, USA,
2Structural Biology Brussels, Vrije Universiteit Brussel, and
3Department of Structural Biology, VIB, Vrije Universiteit Brussel, B-1050, Brussel
Received July 11, 2011; Revised September 27, 2011; Accepted September 28, 2011
ABSTRACT
The parasite Trypanosoma brucei, the causative
agent of sleeping sickness across sub-Saharan
Africa, depends on a remarkable U-insertion/
deletion RNA editing process in its mitochondrion.
A approximately 20S multi-protein complex, called
the editosome, is an essential machinery for editing
pre-mRNA molecules encoding the majority of mito-
chondrial proteins. Editosomes contain a common
core of twelve proteins where six OB-fold inter-
action proteins, called A1–A6, play a crucial role.
Here, we report the structure of two single-strand
nucleic acid-binding OB-folds from interaction
proteins A3 and A6 that surprisingly, form a
heterodimer. Crystal growth required the assistance
of an anti-A3 nanobody as a crystallization chaper-
one. Unexpectedly, this anti-A3 nanobody binds to
both A3
OB and A6, despite only  40% amino acid
sequence identity between the OB-folds of A3 and
A6. The A3
OB-A6 heterodimer buries 35% more
surface area than the A6 homodimer. This is
attributed mainly to the presence of a conserved
Pro-rich loop in A3
OB. The implications of the
A3
OB–A6 heterodimer, and of a dimer of
heterodimers observed in the crystals, for the archi-
tecture of the editosome are profound, resulting in a
proposal of a ‘five OB-fold center’ in the core of the
editosome.
INTRODUCTION
Trypanosomatids form an ancient group of unicellular eu-
karyotes which contain several pathogens causing major
global diseases. These include sleeping sickness, Chagas
disease and various forms of leishmaniasis caused by,
Trypanosoma brucei, Trypanosoma cruzi and a group of
Leishmania species, respectively. The current treatments
of infected patients needs major improvement due to
serious shortcomings of the available drugs and increased
drug resistance (1–4). In particular since antigenic vari-
ation makes vaccine development for these organisms ex-
ceedingly challenging, there is an urgent need to develop
new drugs for treatment of patients suffering from the
global diseases caused by these devastating protozoa.
Trypanosomatids harbor many unusual features (5–7),
several of which are promising drug targets. Particularly
interesting is a unique and extensive mRNA editing
process in mitochondria. This U-insertion/deletion
process edits ‘pre-mRNA’ transcribed from approximately
12 ‘cryptogenes’ located on the maxicircles of the mito-
chondrial DNA. Most remarkably, the information for
the transformation of the pre-mRNA into mature
mRNA is distributed over hundreds of guide RNAs
(gRNAs), typically  60nt long, which are mainly
encoded by the kinetoplast minicircles (8–13). In a
complex process, numerous U’s are inserted and several
U’s are deleted from the pre-message to produce the
complete and correct message. The editing process can,
in some cases, lead to more than a doubling of the size
of the pre-message (11). A cascade of enzymatic reactions
is responsible for the insertion of many U’s and the
deletion of a few U’s according to the information in the
gRNAs (14–16). This fascinating process is found only in
trypanosomes and is essential for the life stage of the para-
sites in humans (16–19), making it a unique target for drug
design.
Several multi-protein complexes are involved in
U-insertion/deletion RNA editing. One of these is called
the  20S editosome, hereafter, called the editosome for
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have revealed that the editosome has an elongated shape
with dimensions of  80 by  140 by  200A ˚ (21,22).
A total of about 20 proteins are incorporated into
editosomes (for editosome protein and domain nomencla-
ture, see Supplementary Figure S1) with probably one
copy of each protein in this multi-protein complex
(21,22). Evidence has been provided for the presence of
three different types of editosomes that share a common
core of 12 proteins (16,23–28). Crystal structures of two
key enzymes from this core have been reported so far: the
RNA-editing ligase L1 in complex with Mg-ATP (29), and
the 30-terminal uridylyl transferase (TUTase) T2 in
complex with Mg-UTP (17).
In the editosome core, six OB-fold interaction proteins
(A1–A6) occur and have been shown to be essential for the
functioning of the editosome (24,30–41). The three large
interaction proteins (A1–A3) contain two Zn-ﬁnger motifs
followed by a C-terminal domain which belongs to the
large superfamily of single-strand nucleic acid-binding
OB-folds, also called SSB domains or SSB proteins,
involved in DNA repair, recombination, replication and
RNA transcription (36,42–50). The three smaller inter-
action proteins (A4, A5, A6) have no Zn-ﬁnger motifs
but contain also a C-terminal single-strand nucleic
acid-binding OB-fold (36) (Supplementary Figure S1).
OB-fold proteins form homodimers and often two such
dimers form homotetramers with aligned 2-fold axes and
D2 symmetry.
Each OB-fold interaction protein has its own character-
istics and interaction partners in the editosome. The main
proteins studied in this article are A3 and A6. The
interaction protein A6 is a remarkable multi-functional
OB-fold protein, central to the integrity of the entire
editosome. With  17–23kDa in size dependent on species,
it not only interacts with four interaction proteins
(20,51,52) but also binds poly-U single-stranded RNA
(53). In three crystal structures solved recently, essentially
the same dimer of A6 was observed in all the three
cases (54). The 42kDa interaction protein A3 binds
ssRNA, as well as dsRNA (30) and its C-terminal
OB-fold interacts with A6 and with the editosome
protein B5 (51).
Since crystal growth of A6-containing multi-protein
complexes turned out to be difﬁcult, we explored
nanobodies as crystallization chaperones. Nanobodies
are the variable domains of the single heavy chain
antibodies occurring in cameloids (55). Nanobodies have
been used with great beneﬁt as crystallization chaperones
in several previous instances in our collaborating
laboratories (54,56,57). In the current work, one out of
the two available anti-A3
OB nanobodies was successful
in promoting the growth of well-diffracting crystals.
Here, we describe the 2.5A ˚ crystal structure of a
heterotetramer formed by the OB-fold domains of the
interaction proteins A3 and A6 and two copies of the
same nanobody. This structure is most unusual for two
reasons. First, the heterotetramer contains one copy of the
anti-A3 nanobody
A3Nb14 which interacts with A3
OB and
a second copy of
A3Nb14 interacts with A6. The inter-
action of the
A3Nb14 nanobody with A3
OB is expected
but the interaction with A6 is entirely unexpected since
A6 shares only  40% sequence identity with A3
OB.
Second, this heterotetramer contains a tight heterodimer
of the OB-folds of A3 and A6, the ﬁrst heterodimer of
single strand nucleic acid-binding OB-folds reported so
far, to the best of our knowledge. In addition, two
A3
OB-A6 heterodimers form a heterotetramer in our
crystals. These key features of our crystal structure have
important implications for the architecture of the core of
the editosome.
MATERIALS AND METHODS
Cloning, expression and puriﬁcation of A2
OB–A3
OB–A6
Co-expressing full-length A3 with A6 did result in soluble
protein which was homogeneous after puriﬁcation but
never crystallized, even when anti-A3 or anti-A6
nanobodies were utilized. Ternary complexes of T. brucei
editosome proteins A2
OB,A 3
OB and A6 were produced
using a similar co-expression strategy as described previ-
ously (51). The gene-encoding residues 474–587 of
T. brucei A2 (A2
OB), preceded by an N-terminal
6xHistidine tag and a tobacco etch virus (TEV) protease
cleavage site, was cloned into a pRSF vector (Novagen).
The gene for T. brucei A6 (residues 20–164, i.e. with the
mitochondrial signal sequence removed) and the
gene-encoding residues 245–393 of T. brucei A3 (A3
OB)
were cloned into the bi-cistronic expression vector
pACYC (Novagen) without His-tag. The pRSF vector
containing the gene for A2
OB was co-transformed with
the A6-A3
OB containing pACYC vector into Escherichia
coli BL21-Gold (DE3) cells. Cells were grown to an OD600
of  0.6 at 37 C in Luria broth and induced with 0.5mM
IPTG at 20 C for 4h. For SeMet substituted protein, ex-
pression was carried out in M9 minimal medium supple-
mented with amino acids and selenomethionine (58). Cells
were lysed by sonication on ice. Soluble proteins were
separated by centrifugation (30min, 60000g, at 4 C)
from the cell pellet. The protein in the supernatant was
puriﬁed on a Ni–NTA column using 250mM imidazole,
treated with TEV protease, puriﬁed further by a second
Ni–NTA afﬁnity step, and subjected to a ﬁnal gel ﬁltration
run on a Superdex 200 gel ﬁltration column using 20mM
Tris–HCl pH 8.0, 300mM NaCl, 1mM tris(2-
carboxyethyl)phosphine hydrochloride (TCEP) and 10%
glycerol.
Production of anti-A3 nanobodies
A3 protein with the import signal removed, spanning
residues 47–393, was expressed from a pRSF plasmid in
E. coli BL21-Gold (DE3) cells and puriﬁed similarly as the
ternary protein complex described above. This protein was
used for llama immunization, and subsequent selection of
A3-speciﬁc nanobody clones using procedures essentially
as described previously (56,57). Out of the 14 nanobodies
obtained, two nanobodies,
A3Nb14 and
A3Nb8, appeared
to bind to the ternary complex A2
OB–A3
OB–A6.
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For the crystallization experiments, recombinant T. brucei
A2
OB–A3
OB–A6 and anti-A3 nanobodies were puriﬁed
separately, mixed at equimolar concentrations and
incubated for 1h at 4 C. Next, the protein mixtures
were concentrated to 5mg/ml and chromatographed on
a Superdex 200 gel ﬁltration column (GE Healthcare) in
20mM Tris (pH 7.5), 300mM NaCl, 1mM TCEP and
10% glycerol. Crystals from the peak fraction containing
A2
OB–A3
OB–A6 and
A3Nb14 were obtained at room tem-
perature by vapor diffusion experiments after mixing 200
nl of protein solution with 200 nl of a reservoir solution of
0.1M HEPES pH 7.5, 10% 2-propanol, 22% w/v
polyethylene glycol (PEG) 4000 by a Phoenix crystalliza-
tion robot. A2
OB–A3
OB–A6 protein obtained from SeMet
containing medium was also mixed with
A3Nb14 protein
solution and crystallized in essentially identical conditions.
All crystals were soaked stepwise in cryo-protective solu-
tions containing the mother liquor plus 20% (v/v) glycerol
before being ﬂash-cooled in liquid nitrogen for data col-
lection. A 2.5A ˚ native data set and a 2.9A ˚ multiple-
wavelength anomalous diffraction (MAD) data set were
collected on beamline BL12-1 at the Stanford Synchrotron
Radiation Lightsource (SSRL). The X-ray diffraction
data were integrated and scaled with HKL2000 (59).
Structure determination and reﬁnement
An initial structure was solved by MAD phasing using
data collected from a crystal containing SeMet substituted
protein. The program SOLVE (60) was used to locate the
positions of the three Se atom sites. Initial phases were
calculated using the SHELX programs at 2.9A ˚ resolution.
After density modiﬁcation by RESOLVE (60), most of the
residues were automatically built by Buccaneer (61). An
unreﬁned and partial poly-alanine model was placed suc-
cessfully by PHASER (62) in the 2.5A ˚ resolution native
crystals. The ﬁnal model was improved and completed
manually using the program COOT (63) and reﬁned
with the programs REFMAC5 (64) and Phenix (65),
with 8 Translation/Libration/Screw (TLS) groups per
asymmetric unit (66). Crystallographic data collection
and reﬁnement statistics are shown in Table 1. In the
ﬁnal model, there are four chains in the asymmetric unit,
which comprise residues 283–393 of A3
OB, residues 20–
132 of A6 and residues 3–128 of both
A3Nb14
molecules. The residues with weak density in A3
OB are
283–287, and in A6 are 129–132. Representative electron
densities in interface regions are shown in Supplementary
Figure S8. The quality of the crystal structure was
analyzed using MolProbity (67).
Figure preparation
Least squares analysis to determine the structural similar-
ity between A3
OB and A6 was carried out using LSQKAB
and DaliLite (68). Protein quaternary-structure analysis
was performed with the PISA server (69). Sequence align-
ment ﬁgures were made with Espript (70). Electrostatic
potential surfaces were calculated using APBS (71). All
other ﬁgures of molecular structures were prepared using
PyMOL (DeLano Scientiﬁc Research LLC).
RESULTS
Protein preparation and structure determination
Obtaining a complex of multiple OB-folds from editosome
interaction proteins which is homogeneous in size and
composition appeared to be challenging. Eventually, a
complex of A2
OB–A3
OB–A6 could be prepared
(Supplementary Figure S2) which had the unfortunate
property that the A2
OB content decreased over time.
Perhaps not too surprisingly therefore, no crystals of
this A2
OB–A3
OB–A6 complex could be obtained. Given
the obstacles encountered, the power of nanobodies
as crystallization chaperones was evaluated. Initially,
14 nanobodies were isolated from an immune library
generated against essentially full-length A3. From this
set of nanobodies,
A3Nb14 and
A3Nb8 (Supplementary
Figure S3) appeared to bind to the A3
OB–A6 complex
according to electromobility shift analysis (EMSA) (data
not shown). After mixing the A2
OB–A3
OB–A6 complex
with
A3Nb14, well-diffracting crystals grew eventually
from which a preliminary structure could be obtained by
MAD phasing (See ‘Materials and Methods’ section).
Surprisingly, the asymmetric unit contained only two
OB-fold proteins which formed a tight dimer. One of
these OB-folds did not contain any SeMet sites and there-
fore, was the A6 monomer. From the distribution
of SeMet sites along the chain of the second OB-fold it
was evident that it was A3
OB (Supplementary Figure S4).
Hence, a heterodimer of A3
OB–A6 is present in the
crystals. Remarkably, no density representing the
A2
OB monomer was discernable. The absence of this
monomer was conﬁrmed by sodium dodecyl sulfate –
polyacrylamide gel electrophoresis (SDS–PAGE) analysis
of dissolved crystals which showed the presence of A3
OB,
A6 and
A3Nb14, but not of A2
OB (Supplementary Figure
S2). In addition to containing a heterodimer of OB-folds,
a second surprise was that A3
OB and A6 were each
interacting with an
A3Nb14 nanobody, yielding an
A3
OB–A6-(
A3Nb14)2 heterotetramer (Figure 1). The
same immunoglobulin chain apparently interacts with
two proteins which share only  40% sequence identity.
The preliminary model derived from the SeMet MAD
electron density was used as a starting point for reﬁnement
against the 2.5A ˚ data from a native crystal that belonged
to the same space group. This eventually resulted in a
reﬁned structure with Rwork and Rfree values of 20 and
23.4%, respectively, with good statistics (Table 1).
Monomers, dimer and tetramer
The main structural elements of both the A3
OB and A6
monomers are a six-stranded anti-parallel b-barrel with a
Greek key motif, helix a1 linking b3 and b4, and three
b-hairpin loops (L12, L23 and L45) extending out of a
globular core b-barrel (Figure 1). Superimposing
A3
OB onto A6 results in an r.m.s.d. of 1.2A ˚ for 91 equiva-
lent Ca atoms. The main structural differences between
the A3
OB and A6 monomers are localized in loop L23
1830 Nucleic Acids Research, 2012,Vol.40, No. 4and the b4–b5 hairpin (Figure 2A). The two monomers
are related by a pseudodyad which is perpendicular to the
extended b-sheet formed by an anti-parallel pair
of N-terminal b-strands of each monomer. The binding
of the nanobodies to these two different proteins is such
that the two
A3Nb14 molecules are related by the same
pseudo-2-fold which relates the OB-folds (Figure 1B).
The distribution of charged residues over the surface of
the A3
OB-A6 heterodimer is highly irregular (Figure 3A).
The ‘front’ surface has a preponderance of positive
charges and the ‘back’ surface an excess of negative
charges. The ‘top’ surface is relatively abundant in posi-
tively charged side chains and aromatic residues that are
typically involved in interactions with single-strand RNA
or ssDNA by this class of proteins (47,72–74). In contrast,
the ‘bottom’ surface contains few charged residues and a
large number of branched non-polar residues resulting in a
quite hydrophobic ‘b-surface’ of the heterodimer (Figure
3A).
In the crystals, two A3
OB-A6 heterodimers related by
crystallographic symmetry form a tetramer, in which the
hydrophobic b-surfaces of two A3
OB–A6 heterodimers
face each other, yielding an (A3
OB–A6)2 heterotetramer
(Figure 3B). The total solvent accessible buried surface
in this interface is  2000A ˚ 2 (69). The possible relevance
of this heterotetramer of four OB-folds for the architec-
ture of the editosome will be discussed further below.
Interactions between A3
OB and A6
The interaction between A3
OB and A6 buries 3105A ˚ 2
surface area upon forming the heterodimer. Among the
47 residues from A3
OB and the 43 residues of A6
engaged in intersubunit contacts, ﬁve amino acids from
each subunit are the major players and each contribute
70–150A ˚ 2 to the buried surface area (Supplementary
Table S1). The interaction surface is highly convoluted
but can approximately be described as the sum of three
major areas of contact between the two subunits.
The ﬁrst contact area includes and surrounds the two
antiparallel b1 strands of both OB-folds, contributing to
30% of the total buried interface area (Figure 2B,
Supplementary Tables S1 and S2). Five residues from
strand b1
A3 form main chain hydrogen bonds with six
b1
A6 residues, a feature shared with the A6 homodimer
(54). Different from the A6-A6 dimer, these b1
A3– b1
A6
interactions are in addition stabilized by contacts of the
two N-terminal residues Lys20
A6 and Ser21
A6 with
Table 1. Crystallographic data collection and reﬁnement statistics
Item Native Se Se Se
Data collection
Space group P43212P 4 3212
Cell dimensions
a, b, c (A ˚ ) 74.6, 74.6, 239.9 74.6, 74.6, 239.3
Solvent content (%) 54.9
Peak Inﬂection Remote
Wavelength 0.9792 0.9792 0.9794 0.9116
Resolution (A ˚ ) 50–2.5 50–2.9 50–2.9 50–2.9
Rsym or Rmerge (%) 6.5 (60.2) 0.169 (0.381) 0.103 (0.363) 0.156 (0.376)
I / s(I) 19.8 (3.8) 13.1 (3.1) 20.8 (3.1) 14.7 (2.6)
Completeness (%) 99.9 (100) 97.8 (77.4) 98 (79.1) 98.7 (86.8)
Redundancy 11.5 (11.9) 9.7 (5.9) 10.5 (6.1) 9.9 (5.9)
Reﬁnement
Resolution (A ˚ ) 37–2.5
No. of reﬂections 23086
Rwork/Rfree (%) 19.9/23.4
No. atoms
Protein 3593
Ligand/ion 0
Water 59
B-factors (A ˚ 2)
Protein 72.7
A3
OB 77.2
A6 78.2
A3Nb14(A) 74.3
A3Nb14(B) 61.1
Ligand/ion
Water 66.2
R.m.s.d.
Bond lengths (A ˚ ) 0.0094
Bond angles ( ) 1.3275
Ramachandran plot
a
Preferred (%) 96.09
Allowed (%) 3.48
Outliers (%) 0.43
aRamachandran plot analysis by Molprobity (67). Values in parentheses are for the highest resolution shell.
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A3 and b4
A3. The highly conserved
Ser21
A6 has contacts with not less than seven residues
from A3
OB (Supplementary Table S2).
Amino acids contributing to the second contact area
include residues from b4
A3–L45–b5
A3 and b2
A6–L23–
b3
A6 (Figure 4A and B). The invariant Glu66
A6 side
chain protrudes from strand b4 and forms a hydrogen
bond with the backbone amide of Arg361
A3, and a salt
bridge with the side chain of the same Arg361
A3. Another
salt bridge occurs between Asp68
A6 and Arg363
A3.
Residues Leu362
A3, Arg363
A3 and Met364
A3 from b4
A3
are three of the ﬁve A3 residues contributing each more
than 70A ˚ 2 to the interface, indicating the importance of
this b-strand for the A3–A6 interaction.
In the third contact region, residues from b2
A3–L23–
b3
A3 and b4
A6–L45–b5
A6 interact with each other. The
b2
A6–b3
A6 hairpin shows a large conformational differ-
ence compared to the equivalent region in A3 (Figure
2A). Interestingly, residues Phe320
A3 and Arg100
A6,
which each contribute more than 100A ˚ 2 to this interface,
are in close proximity (Supplementary Figure S8A and
Supplementary Tables S1 and S2). A key point is that
the proline-rich loop L23 of A3
OB is substantially
involved in the A3
OB–A6 dimer formation (Figure 4C),
whereas loop L23 of A6 is not engaged in similar inter-
actions due to a different course of the polypeptide chain
(Figures 2A and 4B).
Comparison of the A3
OB-A6 heterodimer and
the A6 homodimer
The A3
OB–A6 heterodimer and the A6–A6 homodimer
(PDB-ID: 3K7U) can be superimposed with an r.m.s.d.
of 1.2A ˚ for 179 equivalent Ca atoms, indicating that the
general architecture of these dimers is similar (Figure 2B).
The b4–b5 hairpins in the A6 subunits differ in conform-
ation and loop L23 is less well deﬁned in the A6 subunit of
the homodimer (Figure 2C). The 3105A ˚ 2 surface area
buried in the A3
OB–A6 heterodimer is considerably more
than the 2015A ˚ 2 buried in the formation of the A6
homodimer (54). The major additional contacts in the
heterodimer interface (Figure 4A) are due to (i) extra
contacts by N-terminal residues of A3 and (ii) the different
conformation of loop L23 of A3
OB which allows contacts
with more A6 residues than occur in the A6 dimer.
Clearly, according to the structure, formation of the
A3
OB–A6 heterodimer is more favorable than that of the
A6–A6 homodimer, in agreement with the fact that during
co-expression, the A3–A6 dimer is formed.
The cognate
A3Nb14-A3
OB and the cross-reacting
A3Nb14-A6 interfaces
The interface between the
A3Nb14 and its cognate antigen
A3
OB is formed by 29 residues contributed by
A3Nb14 and
22 residues by A3
OB, resulting in a total buried surface
area of 1775A ˚ 2 (Figure 5 and Supplementary Figure
S3). All three complementarity deﬁning regions (CDRs)
of the nanobody make speciﬁc contacts with A3
OB
(Supplementary Figure S3). Additionally, nine residues
participating in the interaction with A3
OB are highly
conserved framework residues of the nanobody.
The majority of cognate contacts occur between CDR3
of the nanobody and b1–b2 (residues 302–313) of A3
OB.
This interface alone accounts for 61% of the buried
surface, and will hereafter be called Recognition Area 1.
On the A3
OB surface, Recognition Area 1 is separated
from that of Recognition Area 2 which is formed mainly
by residues from strands b4 and b5. The footprints of
these two Recognition Areas on A3
OB are approximately
perpendicular to each other (Figure 5B). Recognition area
1 contains Phe307
A3 which, with 157A ˚ 2, is the A3
OB
Figure 1. Structure of heterotetramer and heterodimer. (A) Sequence
alignment of A3
OB and A6. A schematic representation of full-length
A3 and full-length A6 with their OB-fold domain and the zinc ﬁnger
domains (Z) shown in the upper panel. A3
OB and A6 sequences
(acronyms provided on the left) are aligned in the lower panel.
Strictly conserved residues in both sequences are in red boxes.
Secondary structure elements are indicated on top and below. Red
and blue spheres indicate residues forming the A3
OB–A6 interface;
red triangles the interface residues of the A6 dimer (PDB-ID: 3K7U)
(54). (B) The A3
OB–A6-(
A3Nb14)2 heterotetramer. The heterotetramer
is shown perpendicular to the pseudo-2-fold axis relating the OB-folds
of A3
OB and A6. A3
OB is depicted in magenta; A6 in yellow;
A3Nb14 in
complex with A3
OB in blue;
A3Nb14 in complex with A6 in green. The
heterotetramer depicted is part of an [A3
OB–A6–(
A3Nb14)2]2
heterooctamer occurring in the crystal lattice (Supplementary Figure
S7). (C) The A3
OB–A6-heterodimer. A view along the pseudo-2-fold
of the A3
OB–A6 dimer of the heterotetramer shown in (B) is in the
same color code. The N-terminal b-strands b1 of each monomer run
anti-parallel to each other in the center of an extended b-sheet.
1832 Nucleic Acids Research, 2012,Vol.40, No. 4residue contributing most to the contacts with the
nanobody (Supplementary Table S3). Important contact
residues of
A3Nb14 are Arg101 and Phe102 of CDR3, the
only nanobody residues contributing each more than
100A ˚ 2 to the buried surface. The Phe102 side chain of
A3Nb14 ﬁts into a deep pocket in the center of
Recognition Area 1 of A3
OB (Figure 5B and C;
Supplementary Figure S8).
Nanobody
A3Nb14, raised against A3, interacts also
with A6 (Figure 1). The unexpected ‘cross-reacting’
A6-
A3Nb14 interface buries 1673A ˚ 2 solvent accessible
surface area contributed by 23 residues of
A3Nb14 and
22 residues of A6. Of the amino acids of A3
OB and A6
recognized by CDRs, about 71% are identical between
A3
OB and A6 (Figure 5 and Supplementary Table S3).
Many identical or similar contact residues between A3
OB
and A6 are clustered in Interaction Region 1. For
instance, like its counterpart Phe307
A3, Tyr40
A6 is the
major contributor from A6 to the interface, with 118A ˚ 2
buried surface area (Supplementary Table S3). Also, the
Phe102 side chain of
A3Nb14 ﬁts into a deep pocket in the
center of Recognition Area 1 of A6, very similar to the
mode of binding of Phe102 of the nanobody to its cognate
antigen A3 (Figure 5B and C). Interaction Region 2 is
more different in the two cases. The largest variation
occurs here in the b4–b5 hairpin where Asp369, Tyr368,
Gly370 and Tyr375 of A3
OB are replaced by Cys109,
Asn110, Lys111 and Glu106 in A6 (Supplementary
Table S3). Interestingly, these residues only interact with
framework residues of
A3Nb14 indicating that Contact
Region 2 is largely involved in non-speciﬁc interactions.
DISCUSSION
Cross-reactivity of
A3Nb14 with A3
OB and A6
Crystal structures of the same immunoglobulin domain in
complex with two different proteins appear to be rare. To
the best of our knowledge, there are only two previous
reports of structures with the same antibody in complex
with different proteins, if we ignore the special case of
idiotype:anti-idiotype complexes. The ﬁrst example is
provided by the structures of guinea fowl lysozyme and
hen egg white lysozyme in complex with Fab F9.13.7
generated against hen egg white lysozyme (75). In this
case, the two lysozymes bound to the same Fab are 81%
identical in amino acid sequence. A second example is Fab
F8.12.19 generated against the surface protein AMA1
from the malaria parasite Plasmodium vivax that
cross-reacts with the homologous protein from several
Figure 2. Comparison of A3
OB and A6. (A) Superposition of the A3
OB and A6 chains from the A3
OB-A6 heterodimer. The A3
OB chain is shown in
magenta; A6 from the A3
OB–A6 heterodimer in yellow. Note the large conformational differences in the L23 loop, as well as in the b4–b5 hairpin.
(B) Superposition of the A3
OB–A6 and A6–A6 dimers. A view along the pseudodyad of the heterodimer. The A3
OB chain is shown in magenta; A6
from the A3
OB–A6 heterodimer in yellow; both A6 subunits from the A6–A6 homodimer in blue (PDB-ID: 3K7U) (54). (C) Superposition of A6 in
the A3
OB-A6 heterodimer and A6 in the A6 homodimer. A6 from the heterodimer is depicted in yellow; A6 from the homodimer in blue (PDB-ID:
3K7U) (54). Note that the L23 loop, as well as the b4–b5 hairpin of A6 is better ordered in the A3
OB-A6 heterodimer than in the A6 dimer.
Nucleic Acids Research,2012, Vol.40, No. 4 1833Plasmodium species. The crystal structures of complexes of
Fab F8.12.19 with fragments of Plasmodium falciparum
AMA1 and with P. vivax AMA1 have been elucidated.
These two AMA1 proteins share 67% amino acid
sequence identity (76). The monoclonal antibody Fab
F8.12.19 recognizes a discontinuous epitope, with the
major contact region, a loop with a cysteine knot, and
interacts mainly with conserved residues in these two
proteins.
Nanobody
A3Nb14 interacts with two proteins which
share only  40% amino acid sequence identity. This is a
substantially lower amino acid sequence identity than in
the two above-mentioned reports on structures of
cross-reacting immunoglobulin domains. The two copies
of
A3Nb14 in the A3
OB–A6-(
A3Nb14)2 heterotetramer
have an r.m.s.d. of only 0.45A ˚ for 125 residues, with the
largest difference of  1A ˚ for the Ca of Arg101 of CDR3.
Apparently, nanobody
A3Nb14 can form a complex with
two different proteins while maintaining essentially the
same conformation. The interactions of
A3Nb14 with A3
and A6 reveals that the target proteins have two rather
separate interaction areas with the nanobody (Figure 5).
This is reminiscent of the Fab F8.12.18 complexes with the
AMA1 domains mentioned above. Interaction Regions 1
of A3
OB and A6 provide a similar deep pocket which
buries a protruding side chain from CDR3 (Figure 5). In
contrast, Interaction Region 2 is rather smooth.
Interaction Region 1 of the epitope differs little in struc-
ture when comparing A3 and A6 with an r.m.s.d. for Ca
atoms of 0.45A ˚ with 70% sequence identity for 10 amino
acids. The differences in Interaction Region 2 are larger
with an r.m.s.d. of 2.9A ˚ with 27% sequence identity for 11
amino acids. It would obviously be interesting to know the
afﬁnities of
A3Nb14 for A3
OB and A6. Unfortunately,
determining these afﬁnities is not trivial. First, A3
OB by
itself is insoluble. Second, while A6 by itself forms soluble
homotetramers (54) and nanobody
A3Nb14 does bind to
A6, gel ﬁltration and SDS–PAGE analysis reveals that the
homotetramer dissociates, resulting in formation of
(A6-
A3Nb14)2 heterotetramers (data not shown). The sim-
ultaneous processes of nanobody binding and tetramer
dissociation makes determining the afﬁnity of
A3Nb14
for A6 a challenge.
The A3
OB–A6 heterodimer and tetramer
versus the architecture of the editosome
The A3
OB–A6 heterodimer structure is the ﬁrst example of
a heterodimer in the widely studied single-strand nucleic
acid-binding OB-fold family (72,73,77–80). This unique
A3
OB–A6 heterodimer appears to be quite similar to that
of the A6 homodimer (54), in spite of the fact that the
A3
OB and A6 chains share only  40% sequence identity
(Figure 1A). Important for the architecture, and probably
also for the biogenesis of the editosome, is that the inter-
face in the A3
OB–A6 heterodimer is  35% larger than in
the A6 homodimer. The main contribution to this
enlarged interface stems from extra interactions of the
proline-rich L23 loop in A3 with A6. The sequence of
L23
A3, including the prolines, is highly conserved in
trypanosomatids (Supplementary Figure S5) and so are
the residues of A6 interacting with L23
A3
(Supplementary Figure S6 and Supplementary Table S1).
Hence, it is likely that the A3
OB–A6 heterodimer is
occurring in the actual editosome as well.
Figure 3. Characteristics of A3
OB–A6 heterodimer and heterotetramer.
(A) Surface charge distribution. Four views of the surface charge dis-
tribution of the A3
OB–A6 heterodimer. The electrostatic potential
surface of the A3
OB and A6 dimer is calculated using APBS (71) and
displayed as blue for a positively charged surface potential, red for
negative and gray for neutral. The ‘front surface’ (upper left) is pre-
dominantly positively charged and the ‘back surface’ (upper right) pre-
dominantly negative. The ‘top’ view (lower left) shows pockets of
positively charged surface areas next to the protruding b4–b5 hairpin.
The ‘b-surface’ (lower right), formed mainly by the extended b-sheet of
the dimer, contains large hydrophobic areas (gray). (B) The ‘shifted
tetramer’ formed by two A3
OB-A6 heterodimers in the crystal. The
A3
OB and A6 proteins in the complex are shown in surface mode,
with the two A3
OB chains in magenta and the two A6 domains in
yellow. The b-surfaces of two A3
OB–A6 heterodimers contact each
other in the crystals. The  2000A ˚ 2 total solvent accessible surface
buried in this dimer–dimer interface is composed of  800A ˚ 2 from
A3
OB–A3
OB0
contacts,  600A ˚ 2 contributed by A3
OB–A6
0
,  600A ˚ 2 by
A3
OB0
–A6. The A6 and A6
0
subunits do not interact, while A3
OB inter-
acts with three different OB-folds in this assembly. This (A3
OB–A6)2
heterotetramer is distinct from canonical OB-fold homotetramers (78)
in that the upper and lower dimer pseudo-dyads are not coinciding, but
are shifted with respect to each other parallel to the interacting
b-surface (See arrows representing pseudo-dyads in the upper and
lower heterodimers).
1834 Nucleic Acids Research, 2012,Vol.40, No. 4Interaction protein A6 is a remarkable editosome
protein since it engages with not less than four other
editosome proteins and with RNA (35,37,51–53,81). A
most intriguing question is how this central interaction
protein in the core of the editosome is surrounded by
so many other proteins. In the present structure we see
for the ﬁrst time how A6 and the OB-fold of A3
OB
form extensive interactions. A major remaining
question is how the A3
OB-A6 heterodimer contacts
other OB-folds in the editosome. By a combination
of yeast-two hybrid and biochemical studies, the fol-
lowing binary interactions involving A6 have been un-
covered previously:
(i) the interaction of A6 with A1
OB [Figure 3B in Ref.
(51)];
(ii) the interaction of A6 with A2
OB [Figures 2A and 4A
and B in Ref. (51)];
Figure 4. Interactions in A3
OB–A6 compared with those in A6–A6. (A) The ﬁngerprint of A3
OB on A6 is larger than that of A6 on A6. The
interactions are ‘painted’ onto the surface of A6. Red: the contact area which is the same in the A3
OB–A6 heterodimer and in the A6 homodimer.
Green: the extra contact area in the heterodimer compared with the homodimer. Yellow: the surface of A6 neither in contact with A3
OB in the
heterodimer, nor with the second A6 subunit in the homodimer. The surface buried in the interaction in A3
OB–A6 is  35% larger than in the A6–A6
dimer (PDB-ID: 3K7U)(54). (B) Strands b2–b3 of A6 contacting A3
OB. A stereo view of the ‘second contact area’ (see text) of A3–A6 with important
residues highlighted shown in ribbon representation with the same color coding as in Figure 1B. The secondary structure elements and key residues
mediating the A3–A6 dimer interactions are labeled. (C) The Pro-rich L23 loop of A3
OB contacting A6. A stereo view, 180  different about the
vertical axis from (B), of the ‘third contact area’ (see text) in the heterodimer shown with stick representations. Selected secondary structure elements
and key contact residues are labeled. A3 is colored magenta, A6 yellow-gold.
Nucleic Acids Research,2012, Vol.40, No. 4 1835(iii) the interaction of A6 with A3
OB [Figures 2A and 4C
and D in Ref. (51)];
(iv) the interaction of A6 with A4
OB [Figure 2A in Ref.
(51)].
Moreover, a ternary complex of A2
OB,A 3
OB and A6
has been obtained [Figure 7D in Ref. (51)]. In addition, we
have performed pull-down experiments which indicate
that ternary complexes of A1
OB,A 3
OB and A6 and of
A4
OB,A 3
OB and A6 also exist (Supplementary Figure S9).
Interestingly, a suggestion for the mode of association
of multiple OB folds in the center of the editosome core
comes from the (A3
OB-A6)2 heterotetramer observed in
the crystals (Figure 3 and Supplementary Figure S7).
This heterotetramer is reminiscent of canonical
homotetramers of single-strand nucleic acid-binding
OB-folds. These homotetramers have D2 symmetry. In
the canonical arrangement, the so-called P-dyad of the
OB-fold tetramer is shared by the two dimers, i.e. the
Figure 5. The A3
OB–
A3Nb14 and A6–
A3Nb14 complexes. (A) Sequences and interface residues of A3
OB and A6 with
A3Nb14. Structure-based
alignment of the T. brucei A3 sequence (upper line) and A6 sequence (lower line). Residues highlighted in red are completely conserved. Blue
spheres indicate A3 residues in contact with nanobody
A3Nb14. Green sphere residues of A6 are residues in contact with the second copy of
nanobody
A3Nb14 in the heterotetramer. (B) Footprints of
A3Nb14 onto A3
OB (left) and onto A6 (right). Interaction Region 1 is outlined by an
ellipse with a solid line; Interaction Region 2 with a dashed line. Left: dark blue: A3
OB residues contacting
A3Nb14 residues which are identical in A6;
Light blue: A3
OB residues contacting
A3Nb14 residues which are different in A6; Magenta: A3
OB atoms not contacting the nanobody. Right: dark
green: A6 residues contacting
A3Nb14 residues which are identical in A3
OB; light green:
A3Nb14 residues-contacting residues of A6 which are different
in A3
OB. Yellow: A6 atoms not contacting the nanobody. (C) Key interactions of
A3Nb14 with A3 (left) and of
A3Nb14 with A6 (right). Close-ups of
Interaction Region 1 of both A3 and A6 are shown in stick representations. Residues involved in protein–protein interactions are indicated and
colored according to the molecules they belong to. Colors: A3
OB in magenta with its
A3Nb14 bound in blue, A6 in yellow-gold with its
A3Nb14
bound in green. Nitrogens blue, oxygens red.
1836 Nucleic Acids Research, 2012,Vol.40, No. 42-fold axes of the two dimers coincide (78). But a consid-
erable variation is observed regarding the orientation of
the two dimers with respect to each other
(74,77,79,80,82,83). As a result, the buried surface area
in dimer–dimer interfaces of canonical OB-fold tetramers
is highly variable, ranging from 1128 to 3563A ˚ 2
(PDB-IDs: 1EQQ, 1X3E, 1UE1, 2FXQ, and 2VW9).
The  2000A ˚ 2 buried by the dimers in the (A3
OB–A6)2
heterotetramer in our crystals is clearly within the range
seen for canonical OB-fold homotetramers.
In both the canonical OB-fold tetramer and in the
(A3
OB–A6)2 heterotetramer, the b-surfaces of the dimers
face each other (Figure 3B). However, in contrast to this
common feature, there is also a major difference: the
2-fold axes of the two A3
OB–A6 heterodimers do not
coincide in this heterotetramer, since the two A3
OB–A6
dimers are shifted parallel to the b-surface with respect
to each other. In a canonical OB-fold homotetramer
these 2-fold axes coincide. As a result, one OB-fold in
the ‘shifted heterotetramer’ interacts with all three other
OB-folds (Figure 3B). This ‘shifted heterotetramer’ serves
as a source of inspiration to combine the available
solution studies on binary and ternary interactions, listed
above, with the new A3
OB–A6 structure to arrive at a
model for a ﬁve OB-fold complex in the editosome core.
In this ﬁve OB-fold model, OB-folds from four different
editosome proteins are arranged as a shifted
heterotetramer (Figure 6A) in such a way that A6 interacts
with the OB-folds of three other interaction proteins
(35,51), and one additional OB-fold interacts with A6 in
a different, yet unknown, manner. The A3
OB–A6
heterodimer seen in our current structure is the corner-
stone of this model. While the mutual positions of A3
OB
and A6 are known from our structure, which of the three
other OB-folds occupies which position in the ﬁve OB-fold
model remains to be established. Hence, there are six
variants of the model possible by interchanging A1
OB,
A2
OB and A4
OB.
If the assembly of OB-folds in the core of the editosome
would be as in our ﬁve OB-fold model, then this would
have interesting implications for how the editosome might
function. After all, the three large interaction proteins A1,
A2 and A3 contain extra N-terminal domains which
interact, directly or indirectly, with enzymes in the
editosome (27,32,35,51,52,81,84,85). These enzymes
perform the crucial steps in the RNA editing cascade,
i.e. cleaving the pre-mRNA strand at speciﬁc sites,
removing and inserting U’s and sealing the chain again
(16,28,84,86–88). The catalytic domains of the RNA
ligases L1 and L2, the TUTase T2 and of the 30!50exo-
nuclease X2 are linked to OB-folds via ﬂexible linkers
between the multiple domains in the full length A1 and
A2 proteins. The endonucleases N1, N2 and N3 and the
30!50exonuclease X1 are linked to A3 in the OB-fold
center via one, or possibly even two, interaction proteins
(36,51,52). This arrangement (Figure 6B) then suggests
that the ﬁve or six [this number is dependent on the
editosome type (28)] catalytic domains of the enzymes sur-
rounding the ﬁve OB-fold center display a substantial
degree of mobility enabling the active sites to reach the
editing site of the mRNA.
Figure 6. An OB-fold center in the core of the editosome. (A) Model
for a ‘‘ﬁve OB-fold’’ center of the editosome. The basis is a shifted
heterotetramer (in this example, comprising the OB-folds of A1, A2, A3
and A6) plus an additional A4
OB fold interacting with A6. Please note
that while the A3
OB–A6 heterodimer is experimentally observed, the
positions of A1
OB,A 2
OB and A4
OB in this ﬁgure can be interchanged
and still yield a model in agreement with the experimental constraints
mentioned in the text. Therefore, the arrangement shown is one of six
possible models of these ﬁve OB-folds forming the center of the
editosome core. (B) The same ﬁve OB-fold center as in (A) with the
additional domains in the OB-fold interaction proteins shown as
ribbons and the proteins interacting with these domains outlined as
silver ellipsoids. Note that three different types of editosomes have
been reported to exist, containing either N1-B6, or N2-B7, or
N3-B8-X1, in addition to the core (52). (C) A global outline of how
a pre-mRNA gRNA duplex might interact with the ﬁve OB-fold center
shown in (A). The gold wires indicate RNA, with the duplex in the
anchor region shown as crossbars, and the poly-U tail of the mature
gRNA as a series of U’s. The arrow points to an editing site. The
surrounding enzymes might display mobility with respect to the ﬁve
OB-fold center. See also text.
Nucleic Acids Research,2012, Vol.40, No. 4 1837Results of studies on the RNA-binding properties of
OB-folds can be added to this schematic picture. A4 has
recently been shown to have very high afﬁnity for poly-U,
A3 has a high afﬁnity for dsRNA, and A6 a weak afﬁnity
for poly-U (30,38,53). These data lead to a possible asso-
ciation of the pre-mRNA gRNA duplex with the
editosome OB-fold center as sketched in Figure 6C.
Establishing whether or not this model captures the
global features of the architecture and mechanism of the
editosome requires obviously additional experimental
studies.
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